The protective effect of kefir and vitamin C on azoxymethane induced toxicity and induction of metallothionein in mice

Scandinavian Journal of Laboratory Animal Science

Volumn 32, Issue 4, 2005, Pages 211-220

  Sozmen, Mahmut ^a   Erginsoy, S D ^a   Cenesiz, S ^a   Devrim, A K ^a  

^a KAFKAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; AZOXYMETHANE; LIVER PROTECTIVE AGENT; METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MECHANISM; FEMALE; HENLE LOOP; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KEFIR; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; LIVER CELL; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ANIMALIA;

EID: 33746129171     PISSN: 09013393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Banerjee D, S Onosaka & MG Cherian. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 1982, 24, 95-105.
2. Bogdanov IG. Cultivation of Lactobacillus bulgaricus to produce a ribonucleoproteid. US Patent 1973, 3, 762, 998.
3. Bull LB, CCJ Culvenor & AT Dick. The pyrrolizidine alkaloids. In: A Neuberger, EL Tatum (eds.): Frontiers of biology. North Holland Publishing Co., Amsterdam, 1968, pp 187-206.
4. Chen LH, GA Biossonneault & HP Glauert. Vitamin C, vitamin E and cancer. Anticancer Res. 1988, 8, 739-748.
5. Davis SR & Cousins RJ. Metallothionein expression in animals: a physiological perspective on function. J. Nutr. 2000, 130, 1085-1088.
6. Doering CB, CD Josephson, HN Craddock & P Lollar. Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure. Blood 2002, 100, 143-147.
7. Fiala ES, N Caswell, OS Sohn, MR Felder, GD McCoy & JH Weisburger. Non-alcohol dehydrogenase-mediated metabolism of methylazoxymethanol in the deer mouse, Peromycus maniculatus. Cancer Res. 1984, 44, 2885-2891.
8. Furukawa N, A Matsuoka, T Takahashi & Y Yamanaka. Effects of fermented milk on the delayed-type hypersensitivity response and survival in mice bearing Meth-A. Anim. Sci. Technol. 1991, 62, 579-585.
9. Guven A, A Guven & M Gulmez. The effect of kefir on the activities of GSH-Px, GST, CAT, GSH and LPO levels in carbon tetracholoride-induced mice tissues. J. Vet. Med. B 2003, 50, 412-416.
10. Hallé C, F Leroi, X Dousset & M Pidoux. Les kéfirs: des asssociations bactéries lactiques-levures. In: Bactéries lactiques: aspects fondamentaux et technologiques. Lorica, Uriage, France, 1994, pp 169-182.
11. Hamer D. Metallothionein. Annu. Rev. Biochem. 1986, 55, 913-951.
12. Hendrich S & HC Pitot. Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis. Cancer Metast. Rev. 1987, 6, 155-178.
13. Henson DE, G Block & M Levine. Ascorbic acid: biologic functions and relation to cancer. J. Natl. Cancer. Inst. 1991, 88, 547-550.
14. Hoolihan LK. Prophylactic and therapeutic use of probiotics: a review. J. Am. Diet. Assoc. 2001, 101, 220-238.
15. Hunziker PE & JHR Kagi. Isolation and characterization of six human hepatic metallothioneins. Biochem. J. 1985, 231, 375-382.
16. Iverson F, J Campbell, D Clayson, S Hierlihy, E Labossiere & S Hayward. Effects of antioxidants on aflatoxin-induced hepatic tumours in rats. Cancer Lett. 1987, 26, 139-144
17. Kägi JHR. Overview of metallothionein. Method. Enzymol. 1991, 205, 613-626.
18. Kroes R, JM Berkvens, JH Weisburger. Immunosuppression in primary liver and colon tumor induction with N-Hydroxy-N-2-fluorenylacetamide and azoxymethane. Cancer Res. 1975, 2651-2656.
19. Liu JR, SY Wang, YY Lin & CW Lin. Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice. Nutr. Cancer 2002, 44, 182-187.
20. Magee PN & JM Barnes. Carcinogenic nitroso compounds. Adv. Cancer. Res. 1967, 10, 164-246.
21. Margeli AP, SE Theocharis, N Yannacou, C Spiliopoulou & A Koutselinis. Metallothionein expression during liver regeneration after partial hepatectomy in cadmium-pretreated rats. Arch. Toxicol. 1994, 68, 637-642.
22. Marshsall MV & WM Cole. Methods for making kefir and fermented milks based on kefir. J. Dairy Res. 1985, 52, 451-456.
23. Milnerowicz H, M Chmarek, J Rabczynski, S Milnerowicz, S Nabzdyk & W Knast. Immunohistochemical localization of metallothionein in chronic pancreatitis. Pancreas 2004, 29, 28-32.
24. National Institute for Occupational Safety and Health. In: RL Sweet, DV Sweet (eds.): Registry of toxic effects of chemical substances. United States Department of Commerce, Cincinnati, Ohio, 1985, p 1166.
25. Netke SP, MW Roomi, C Tsao & A Niedzwiecki. Ascorbic acid protects guinea pigs from acute aflatoxin toxicity. Toxicol Appl Pharm 1997, 143, 429-435.
26. Nishimura H, N Nishimura & C Tohyama. Immunohistochemical localization and metallothionein in developing rat tissues. J. Histochem. Cytochem. 1989, 37, 715-722.
27. Nishimura H, N Nishimura & C Tohyama. Localization of metallothionein in the genital organs of the male rat. J. Histochem. Cytochem. 1990, 38, 927-933.
28. Oredipe OA, RF Barth, C Dwivedi & TE Webb. Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in rats. Res. Commun. Chem. Pathol. Pharmacol. 1989, 65, 345-359.
29. Ouwehand AC, PV Kirjavainen, C Shortt & S Salminen. Probiotics: mechanisms and established effects. Int. Dairy J. 1999, 9, 43-52.
30. Pitot HC & AE Sirica. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta 1980, 605, 191-215.
31. Shiraishi N, H Uno & MP Waalkes. Effect of L-ascorbic acid pretreatment on cadmium toxicity in the female Fischer (F344/NCr) rat. Toxicology 1993, 85, 85-100.
32. Slauson DO & BJ Cooper. Mechanisms of disease. Williams and Wilkins, Baltimore, Maryland, 1990, pp. 63-64.
33. Tanaka T, BS Reddy & K El-Bayoumy. Inhibition by dietary organoselenium, p-methoxybenzeneselenol, of hepatocarcinogenesis induced by azoxymethane in rats. Jpn. J. Cancer Res. 1985, 76, 462-467.
34. Tanimoto A, T Hamada, K Higashi & Y Sasaguri. Distribution of cadmium and metallothionein in CdC12-exposed rat kidney: relation with apoptosis and regeneration. Pathol. Int. 1999, 49, 125-132.
35. Thomas JP, GJ Bachowski & AW Girotti. Inhibition of cell membrane lipid peroxidation by cadmium and zinc-metallothionein. Biochim. Biophys. Acta 1986, 884, 448-461.
36. Tohyama C, H Nishimura & N Nishimura. Immunohistochemical localization of metallothionein in the liver and kidney of cadmium- or zinc -treated rats. Acta Histochem. Cytochem. 1988, 21, 91-102.
37. Tohyama C, JS Suzuki, J Hemelraad, N Nishimura & H Nishimura. Induction of metallothionein and its localization in the nucleus of rat hepatocytes after partial hepatectomy. Hepatology 1993, 18, 1193-1201.
38. Wargovich MJ, W Satterfield, RE Price, LC Stephens & L Coghlan. Hepatic pathology of the colon carcinogen, azoxymethane, in Hanford-Moore miniature pigs. J. Comp. Path. 1991, 105, 271-278.
39. Webb M. Metallothionein in regeneration, reproduction and development. Experientia Suppl. 1987, 52, 483-498.
40. Wiseman H & B Halliwell. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 1996, 313, 17-29.
41. Woo ES & JS Lazo. Nucleocytoplasmic functionality of metallothionein. Cancer Res. 1997, 57, 4236-4241.
42. World Cancer Research Fund. American institute for cancer research, food, nutrition and the prevention of cancer, 1997.
43. Zacconi C, MG Parisi, PG Sarra, P Dallavalle & V Bottazzi. Competitive exclusion of Salmonella kedougou in kefir fed chicks. Microbiol. Alim. Nutr. 1995, 12, 387-390.
44. Zaidi NH, TP Pretlow, MA O'Riordan, LL Dumenco, E Allay & SL Gerson. Transgenic expression of human MGMT protect against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis 1995, 16, 451-456.